Elmar Schnee
Chairman en CALLIDITAS THERAPEUTICS AB .
Fortuna: 490 355 $ al 31/03/2024
Origen de la red de primer grado Elmar Schnee.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
53
| Public Company | Pharmaceuticals: Major | 53 |
Public Company | Pharmaceuticals: Major | 33 | |
Public Company | Pharmaceuticals: Major | 28 | |
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA.
18
| Subsidiary | Pharmaceuticals: Major | 18 |
Merck Serono SA
Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland.
17
| Subsidiary | Medical Specialties | 17 |
Public Company | Pharmaceuticals: Major | 13 | |
Moleac Pte Ltd.
Moleac Pte Ltd. Pharmaceuticals: MajorHealth Technology Moleac Pte Ltd. develops and distributes biopharmaceutical products. It operates as a bio-pharmaceutical company that develops new medicines for the unmet needs of patients suffering from neurological, cardio-vascular and aging conditions. The firm's flagship product NeuroAiD, helps patients recover faster and better from stroke disabilities. The company was founded by David Picard and Marc Vasseur in 2003 and is headquartered in Singapore.
11
| Holding Company | Pharmaceuticals: Major | 11 |
Holding Company | Pharmaceuticals: Major | 10 | |
EnteroBiotix Ltd.
EnteroBiotix Ltd. Medical SpecialtiesHealth Technology EnteroBiotix Ltd. develops novel microbiome modulating drugs which are composed of live microorganisms. It focuses on faecal microbiota transplantation which transfers bacteria from a healthy donor into a recipient having an infection caused by a bacterium called C.difficile. The company was founded by James Roger McIlroy in March 2017 and is headquartered in Aberdeen, the United Kingdom.
5
| Holding Company | Medical Specialties | 5 |
Kuste Biopharma SAS
Kuste Biopharma SAS Pharmaceuticals: MajorHealth Technology Kuste Biopharma SAS engages in the development of therapies for unmet medical inflammatory. The company was founded in 2019 and is headquartered in Lyon, France.
5
| Holding Company | Pharmaceuticals: Major | 5 |
Subsidiary | Pharmaceuticals: Major | 5 | |
MindMaze SA
MindMaze SA Medical SpecialtiesHealth Technology MindMaze SA engages in the development of a neuro-inspired computing platform that captures brain activity upon intent, creating a new operating system for computers. It also engages in the use of virtual reality to rehabilitate the brains of stroke patients. The company was founded by Tej Tadi in 2012 and is headquartered in Lausanne, Switzerland.
4
| Subsidiary | Medical Specialties | 4 |
Genpharm Services
Genpharm Services Advertising/Marketing ServicesCommercial Services Genpharm Services operates as a pharmaceutical company providing partners with market access and commercial solutions into the Middle East and North Africa region. It also acts as a commercial partner for rare genetic diseases, orphan drugs, and specialty therapeutics and offers strategic advice on disease areas, product launches and go-to markets strategies. The company was founded by Karim Smaira and Kamel Ghammachi in 2012 and is headquartered in Dubai, United Arab Emirates.
4
| Private Company | Advertising/Marketing Services | 4 |
Subsidiary | Miscellaneous Commercial Services | 4 | |
Mindmaze, Inc.
Mindmaze, Inc. Information Technology ServicesTechnology Services Mindmaze, Inc. operates as a computing platform that captures brain activity. The firm develops medical virtual reality products for neural sicknesses. The firm offers MindMotion PRO, is FDA-cleared to bring 3D virtual environment therapy for neuro rehabilitation to patients. The company was founded by Tej Tadi in 2012 and is headquartered in San Francisco, CA.
4
| Holding Company | Information Technology Services | 4 |
Procom RX
1
| Private Company | 1 | |
Cardiorentis AG
Cardiorentis AG Pharmaceuticals: MajorHealth Technology Cardiorentis AG operates as a biopharmaceutical company. It offers novel therapies to the treatment of heart failure and related cardiovascular diseases. The company was founded in 2010 and is headquartered in Zug, Switzerland.
1
| Private Company | Pharmaceuticals: Major | 1 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Elmar Schnee a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
IMMUNOMEDICS, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
ASTRAZENECA PLC | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
CTI BIOPHARMA CORP. | Pharmaceuticals: Major | Treasurer Director/Board Member | |
BAYER AG | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal | |
Acambis Plc
Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | Biotechnology | Director/Board Member Director of Finance/CFO | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Chief Operating Officer Corporate Officer/Principal Corporate Officer/Principal | |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Comptroller/Controller/Auditor | |
SANOFI | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
MOLMED S.P.A. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
OXFORD NANOPORE TECHNOLOGIES PLC | Electronic Equipment/Instruments | Chairman Director of Finance/CFO | |
STALLERGENES | Pharmaceuticals: Major | Chairman Chief Executive Officer Director of Finance/CFO | |
The Boston Consulting Group, Inc.
The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Georgia State University | College/University | Graduate Degree Masters Business Admin | |
State University of New York at Buffalo | College/University | Graduate Degree Masters Business Admin | |
MEDCAP AB | Medical Specialties | Director/Board Member Chairman Director/Board Member | |
Stockholm School of Economics | College/University | Masters Business Admin Undergraduate Degree | |
Technische Universität München | College/University | Doctorate Degree Corporate Officer/Principal | |
NEWRON PHARMACEUTICALS S.P.A. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
SCIBASE HOLDING AB (PUBL) | Medical Specialties | Director/Board Member Director/Board Member | |
Newron Sweden AB
Newron Sweden AB Pharmaceuticals: MajorHealth Technology Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal President | |
WEIFA ASA | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
University of Lund | College/University | Graduate Degree Graduate Degree | |
University of Oslo | College/University | Graduate Degree Doctorate Degree | |
University of Basel | College/University | Director/Board Member Graduate Degree | |
University of Milan | College/University | Corporate Officer/Principal Doctorate Degree | |
Ludwig-Maximilians-Universität München | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
L'Oréal (UK) Ltd.
L'Oréal (UK) Ltd. Wholesale DistributorsDistribution Services L'Oréal (UK) Ltd. produces cosmetics and perfumes. It has various brands in professional products, consumer products, luxury products, active cosmetics and the body shop. The company was founded in 1907 by Eugne Schueller and is located in London, UK. | Wholesale Distributors | Comptroller/Controller/Auditor Corporate Officer/Principal | |
The Royal College of Physicians | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Baden Badener Unternehmergespräche
Baden Badener Unternehmergespräche Miscellaneous Commercial ServicesCommercial Services Baden Badener Unternehmergespräche (bbug) is an institution based in Baden-Baden, Germany that has trained, accompanied, and shaped generations of managers for many decades. The bbug is a platform for valuable exchange and has shaped the value of its participants. The German company is a network of personalities from business, politics, and culture that provides inspiration, competence, commitment, and common enthusiasm. The bbug is an enrichment for every participant and provides impulses for specific activities in the non-profit company and responsible roles in society. The CEO of the company is Karl-Ludwig Kley. | Miscellaneous Commercial Services | Chief Executive Officer Corporate Officer/Principal | |
BERGENBIO ASA | Pharmaceuticals: Major | Corporate Officer/Principal Chairman | |
SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Director/Board Member | |
Verband der Chemischen Industrie eV
Verband der Chemischen Industrie eV Miscellaneous Commercial ServicesCommercial Services Verband der Chemischen Industrie eV operates a chemical industry association. The non-profit company is based in Frankfurt am Main, Germany. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
REDX PHARMA PLC | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
VALNEVA | Biotechnology | Director of Finance/CFO Director of Finance/CFO | |
CELLECTAR BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
GRAIL LLC
GRAIL LLC Electronic Equipment/InstrumentsElectronic Technology GRAIL LLC is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA. | Electronic Equipment/Instruments | Chief Executive Officer Director of Finance/CFO Director of Finance/CFO | |
IXALTIS SAS
IXALTIS SAS Pharmaceuticals: MajorHealth Technology IXALTIS SAS develops therapeutics to treat genitourinary tract disorders with unsatisfied medical need. The company was founded by Christian Chavy, Philippe Lluel, Roberto Gradnik, Stefano Palea, Pascal Rischmann, and Xavier Gamé in 2012 and is headquartered in Archamps, France. | Pharmaceuticals: Major | Founder Director/Board Member Corporate Officer/Principal | |
SEDANA MEDICAL AB | Medical Specialties | Director/Board Member Chairman Director/Board Member | |
Nefecon AB
Nefecon AB Pharmaceuticals: MajorHealth Technology Part of Calliditas Therapeutics AB, Nefecon AB is a pharmaceutical company based in Stockholm, Sweden. The Swedish company has developed a patented oral, delayed release formulation of budesonide called nefecon, which is designed to target mucosal B-cells present in the ileum where the disease originates, as per the predominant pathogenesis models. Nefecon is derived from the targit technology, which allows for the substance to pass through the stomach and intestine without being absorbed, and to be released in a pulse-like fashion only when it reaches the lower small intestine. The private company has completed a large phase 2b trial, which showed that the combination of dose and optimized release profile is required to be effective in patients with IgA nephropathy. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
Busulipo AB
Busulipo AB Pharmaceuticals: MajorHealth Technology Busulipo AB is a Swedish company that manufactures and wholesales pharmaceutical and medical technology products. The private company is based in Stockholm, Sweden. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
GOSSAMER BIO, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Santhera Pharmaceuticals (USA), Inc.
Santhera Pharmaceuticals (USA), Inc. Pharmaceuticals: MajorHealth Technology Santhera Pharmaceuticals (USA), Inc. engages in the provision of regulatory and medical services. The company is headquartered in Burlington, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Gyroscope Therapeutics Ltd.
Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member | |
GYROSCOPE THERAPEUTICS HOLDINGS PLC | Biotechnology | Director/Board Member Director/Board Member | |
E. Merck KG
E. Merck KG Pharmaceuticals: MajorHealth Technology E. Merck KG operates as a holding company with interest in pharmaceutical preparations. It acts as a general partner that holds the majority of shares of the public company Merck KGaA. Merck KG is the parent company of all Merck companies yet it does not have any operating businesses itself. It makes the entrepreneurial policy decisions for the Merck Group. The company is headquartered in Darmstadt, Germany. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal |
Estadísticas
Internacional
Estados Unidos | 16 |
Suecia | 10 |
Reino Unido | 9 |
Alemania | 7 |
Francia | 5 |
Sectorial
Health Technology | 33 |
Consumer Services | 11 |
Commercial Services | 6 |
Electronic Technology | 3 |
Distribution Services | 2 |
Operativa
Director/Board Member | 486 |
Corporate Officer/Principal | 213 |
Chairman | 154 |
Independent Dir/Board Member | 126 |
Chief Executive Officer | 104 |
Las relaciones más conectadas
Insiders | |
---|---|
Thomas Lennart Eklund | 56 |
Frank Armstrong | 41 |
Bengt Åke Julander | 36 |
Karl-Ludwig Kley | 32 |
Karen Wilson | 31 |
David Lawrence | 29 |
Khalid Islam | 29 |
Wolfgang Heinz Büchele | 28 |
Paul Berns | 28 |
Renée Aguiar-Lucander | 26 |
Peter Allen | 26 |
Ann-Tove Kongsnes | 24 |
Laura Iris Ferro | 24 |
Patrick J. Langlois | 23 |
Philip Broadley | 23 |
- Bolsa de valores
- Insiders
- Elmar Schnee
- Conexiones Empresas